These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 12480276)

  • 1. Measurement of agitation force in dissolution test and mechanical destructive force in disintegration test.
    Kamba M; Seta Y; Takeda N; Hamaura T; Kusai A; Nakane H; Nishimura K
    Int J Pharm; 2003 Jan; 250(1):99-109. PubMed ID: 12480276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A better dissolution method for ranitidine tablets USP.
    Cappola ML
    Pharm Dev Technol; 2001; 6(1):11-7. PubMed ID: 11247270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of hydrodynamic environment on tablets dissolution rate.
    Wu Y; Kildsig DO; Ghaly ES
    Pharm Dev Technol; 2004; 9(1):25-37. PubMed ID: 15000464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computational fluid dynamics modeling of the paddle dissolution apparatus: agitation rate, mixing patterns, and fluid velocities.
    McCarthy LG; Bradley G; Sexton JC; Corrigan OI; Healy AM
    AAPS PharmSciTech; 2004 Apr; 5(2):e31. PubMed ID: 15760089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility studies of utilizing disk intrinsic dissolution rate to classify drugs.
    Yu LX; Carlin AS; Amidon GL; Hussain AS
    Int J Pharm; 2004 Feb; 270(1-2):221-7. PubMed ID: 14726137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications.
    D'Arcy DM; Corrigan OI; Healy AM
    Eur J Pharm Sci; 2006 Feb; 27(2-3):259-67. PubMed ID: 16314078
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of dissolution media pH and USP1 basket speed on erosion and disintegration characteristics of immediate release metformin hydrochloride tablets.
    Desai D; Wong B; Huang Y; Tang D; Hemenway J; Paruchuri S; Guo H; Hsieh D; Timmins P
    Pharm Dev Technol; 2015; 20(5):540-5. PubMed ID: 24621340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and validation of dissolution tests for fexofenadine hydrochloride capsules and coated tablets.
    Breier AR; Paim CS; Steppe M; Schapoval EE
    J Pharm Pharm Sci; 2005 Aug; 8(2):289-98. PubMed ID: 16124939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of higher rates of agitation on release patterns of immediate-release drug products.
    Shah VP; Gurbarg M; Noory A; Dighe S; Skelly JP
    J Pharm Sci; 1992 Jun; 81(6):500-3. PubMed ID: 1522485
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disintegration of sublingual tablets: proposal for a validated test method and acceptance criterion.
    Weda M; van Riet-Nales DA; van Aalst P; de Kaste D; Lekkerkerker JF
    Pharmeur Sci Notes; 2006 Dec; 2006(2):41-4. PubMed ID: 17691213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Investigation of the Dissolution Profile of Gliclazide Modified-Release Tablets Using Different Apparatuses and Dissolution Conditions.
    Skripnik KKS; Riekes MK; Pezzini BR; Cardoso SG; Stulzer HK
    AAPS PharmSciTech; 2017 Jul; 18(5):1785-1794. PubMed ID: 27800567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability.
    D'Arcy DM; Corrigan OI; Healy AM
    J Pharm Pharmacol; 2005 Oct; 57(10):1243-50. PubMed ID: 16259752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Temperature, pH and agitation rate as dissolution test discriminators of zofenopril calcium tablets.
    Lozano R; Joseph JM; Kline BJ
    J Pharm Biomed Anal; 1994 Feb; 12(2):173-7. PubMed ID: 8003543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal dissolutions of chlorpromazine hydrochloride tablets in water by paddle method under a high agitation condition.
    Aoyagi N; Rimando AP; Izutsu K; Katori N; Kojima S
    Chem Pharm Bull (Tokyo); 2003 Sep; 51(9):1021-4. PubMed ID: 12951441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Time and temperature dependence of disintegration and correlation between dissolution and disintegration rate constants.
    Carstensen JT; Kothari R; Prasad VK; Sheridan J
    J Pharm Sci; 1980 Mar; 69(3):290-4. PubMed ID: 7381704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on different dissolution models. IV. Erosion of tablets.
    De Haan P; Lerk CF
    Pharm Weekbl Sci; 1982 Dec; 4(6):191-6. PubMed ID: 7155788
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of basket and paddle dissolution methods using different performance standards.
    Prasad VK; Shah VP; Hunt J; Purich E; Knight P; Cabana BE
    J Pharm Sci; 1983 Jan; 72(1):42-4. PubMed ID: 6827462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Minimum rotation speed to prevent coning phenomena in compendium paddle dissolution apparatus.
    Higuchi M; Yoshihashi Y; Tarada K; Sugano K
    Eur J Pharm Sci; 2014 Dec; 65():74-8. PubMed ID: 25240320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of Apex Size on Dissolution Profiles in the USP II Paddle Apparatus.
    Yoshida H; Morita T; Abe Y; Inagaki A; Tomita N; Izutsu KI; Sato Y
    AAPS PharmSciTech; 2023 Dec; 25(1):9. PubMed ID: 38158516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro release testing of matrices based on starch-methyl methacrylate copolymers: effect of tablet crushing force, dissolution medium pH and stirring rate.
    Ferrero C; Jiménez-Castellanos MR
    Int J Pharm; 2014 Jan; 461(1-2):270-9. PubMed ID: 24333902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.